YKL-40 IDENTIFIED BY PROTEOMIC ANALYSIS AS A BIOMARKER OF SEPSIS
The DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.
Abstract
To investigate changes in protein expression by proteomic analysis in the sera of patients with sepsis and to identify new biomarkers of sepsis. A total of 45 consecutive patients with severe sepsis or septic shock (sepsis group), 22 healthy volunteers, and 23 patients undergoing off-pump coronary artery bypass grafting (control group). Serum samples from eight patients of each group underwent proteomic analysis involving removal of 12 major proteins and subsequent reversed-phase high-performance liquid chromatography fractionation and one-dimensional electrophoresis. The intensity of 41 bands (with 12 proteins identified) increased and that of 42 bands (with 22 proteins identified) decreased in the sepsis group. Results of proteomic analysis successfully validated by Western blotting and/or enzyme-linked immunosorbent assay for three proteins (YKL-40, lipocalin 2, and S100A9) increased in the sepsis group as well as two proteins (retinol-binding protein, vitamin D-binding protein) decreased. Serum YKL-40 levels (sYKL-40) on intensive care unit (ICU) admission were assessed by enzyme-linked immunosorbent assay between the two groups; resulting YKL-40 was significantly higher in the sepsis group (P < 0.001). Furthermore, sYKL-40 on ICU admission was significantly higher in patients with positive blood culture (P < 0.005), patients with septic shock (P < 0.05), and patients requiring continuous hemodiafiltration (P < 0.05) or hydrocortisone replacement therapy (P < 0.005) during subsequent treatment. A positive correlation between sYKL-40 and blood IL-6 level on ICU admission was noted in the sepsis group (r = 0.465, P < 0.01). YKL-40 identified by proteomic analysis is considered as a biomarker of sepsis. However, further investigation is needed to clarify its roles and clinical usefulness as a biomarker.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“as is the iron siderophore-binding protein lipocalin-2”
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“The Acute Physiology and Chronic Health Evaluation II (14) and Sequential Organ Failure Assessment scores (15) were also calculated on ICU admission.”
MethodBone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Vincent, J.-L., de Mendonca, A., Cantraine, F., Moreno, R., Takala, J., Suter, P. M., Sprung, C. L., Colardyn, F., & Blecher, S. (1998) · Critical Care Medicine · doi:10.1097/00003246-199811000-00016 · Cited by 3,463 · cited 1×
“The Acute Physiology and Chronic Health Evaluation II (14) and Sequential Organ Failure Assessment scores (15) were also calculated on ICU admission.”
MethodSurviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,321
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,018 · cited 1×
“During the ICU stay, patients with severe sepsis or septic shock were treated according to international guidelines (16).”
Dellinger, R. P. (2004) · Critical Care Medicine · Cited by 1,848
Progress with gene‐product mapping of the Mollicutes: Mycoplasma genitalium
Wasinger, V. C., Cordwell, S. J., Cerpa‐Poljak, A., Yan, J. X., Gooley, A. A., Wilkins, M. R., Duncan, M. W., Harris, R., Williams, K. L., & Humphery‐Smith, I. (1995) · ELECTROPHORESIS · doi:10.1002/elps.11501601185 · Cited by 962
Effect of Variation in CHI3L1 on Serum YKL-40 Level, Risk of Asthma, and Lung Function
Ober, C., Tan, Z., Sun, Y., Possick, J. D., Pan, L., Nicolae, R., Radford, S., Parry, R. R., Heinzmann, A., Deichmann, K. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708801 · Cited by 470 · cited 2×
“First, serum levels of YKL-40 in patients with severe sepsis or septic shock were extremely higher than those in patients with other diseases such as rheumatoid arthritis (22), asthma (23), liver fibrosis (24), Crohn disease (25), acute coronary syndrome (26), and cancer (27).”
BackgroundResult
Cited by
Chitinase-3 like-protein-1 function and its role in diseases
Zhao, T., Su, Z., Li, Y., Zhang, X., & You, Q. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00303-7 · Cited by 536
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“Note, however, that such methods need careful handling from a statistical point of view (e.g. Altman and Royston 2000; Broadhurst and Kell 2006; Hastie et al. 2001; Ioannidis 2005, 2008).”
BackgroundCommon variants of the vitamin D binding protein gene and adverse health outcomes
Malik, S., Fu, L., Juras, D. J., Karmali, M., Wong, B. Y. L., Gozdzik, A., & Cole, D. E. C. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2012.750262 · Cited by 151
Mass spectrometry for the discovery of biomarkers of sepsis
Ludwig, K. R., & Hummon, A. B. (2017) · Molecular BioSystems · doi:10.1039/c6mb00656f · Cited by 113
Chitinase-like Proteins are Candidate Biomarkers for Sepsis-induced Acute Kidney Injury
Maddens, B., Ghesquière, B., Vanholder, R. C., Demon, D., Vanmassenhove, J., Gevaert, K., & Meyer, E. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.013094 · Cited by 98
“This is in agreement with increased plasma CHI3L1 concentrations in humans after endotoxin injection (37) and in patients with severe sepsis and septic shock (38).”
BackgroundInfluential
Metadata
- Authors
- Hattori, N., Oda, S., Sadahiro, T., Nakamura, M., Abe, R., Shinozaki, K., Nomura, F., Tomonaga, T., Matsushita, K., Kodera, Y., Sogawa, K., Satoh, M., & Hirasawa, H.
- Affiliations
- Chiba University (JP)
- Kitasato University (JP)
- Chiba University Hospital (JP)
- Corresponding author
- Hattori, Noriyuki
- Oda, Shigeto
- Sadahiro, Tomohito
- Nakamura, Masataka
- Abe, Ryuzo
- Shinozaki, Koichiro
- Hirasawa, Hiroyuki
- ORCID
- Venue
- Shock
- Published
- 2009-10
- Volume
- 32
- Issue
- 4
- Pages
- 393-400
- ISSN
- 1073-2322 (ISSN-L)
- OpenAlex
- W2077667419
- Cited by
- 83
- References
- 42
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 1 · 2021: 4 · 2020: 4 · 2019: 5 · 2018: 7 · 2017: 1 · 2016: 8 · 2015: 8 · 2014: 5 · 2013: 4 · 2012: 7
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Shock (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- YKL-40, sepsis, septic shock, serum biomarkers, serum proteome, neutrophil gelatinase-associated lipocalin, S100A9, interleukin-6, hydrocortisone replacement, hemodiafiltration, blood culture, intensive care unit admission
- MeSH terms
- Lipocalin-2, Chitinase-3-Like Protein 1, Acute-Phase Proteins, Aged, Chromatography, High Pressure Liquid, Enzyme-Linked Immunosorbent Assay, Female, Glycoproteins, Humans, Male, Middle Aged, Proto-Oncogene Proteins, Retinol-Binding Proteins, Shock, Septic, Vitamin D-Binding Protein, Blotting, Western, Interleukin-6, Sepsis, Lectins, Calgranulin B, Adipokines, Lipocalins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: YKL-40 IDENTIFIED BY PROTEOMIC ANALYSIS AS A BIOMARKER OF SEPSIS. https://app.cochat.ai/papers/10.1097/shk.0b013e31819e2c0c
- The paper
- Hattori, N., Oda, S., Sadahiro, T., Nakamura, M., Abe, R., Shinozaki, K., Nomura, F., Tomonaga, T., Matsushita, K., Kodera, Y., Sogawa, K., Satoh, M., & Hirasawa, H. (2009). YKL-40 IDENTIFIED BY PROTEOMIC ANALYSIS AS A BIOMARKER OF SEPSIS. Shock. https://doi.org/10.1097/shk.0b013e31819e2c0c
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.